Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Callisto initiates phase II extension trial of atiprimod for neuroendocrine cancer

Oct. 29, 2007

Yale Cancer Center begins clinical trial of Marshall Edwards' oral phenoxodiol

Oct. 29, 2007

Primary endpoint met in phase III Treanda trial for indolent NHL

Oct. 29, 2007

Marillion initiates phase I human clinical trial for anticancer drug MN-201

Oct. 29, 2007

APITD1, a candidate tumor suppressor gene in neuroblastoma

Oct. 26, 2007

Oncolytics Biotech receives U.K. approval to evaluate Reolysin

Oct. 26, 2007

Aida identifies potential targets in phase II trial with Rh-Apo2L

Oct. 26, 2007

Genzyme acquires Bioenvision and gains rights to clofarabine

Oct. 25, 2007

Recent patents cover novel discoveries for the treatment of cancer

Oct. 25, 2007

GlaxoSmithKline receives approval for ArranonG in T-ALL and T-LBL

Oct. 24, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...